Real-world experience with ocriplasmin indicates it is an effective, safe, and cost-effective treatment for symptomatic vitreomacular adhesion in properly selected eyes.
Peter W. Stalmans, MD
Advertisement
Articles by Peter W. Stalmans, MD
Advertisement
Latest Updated Articles
- Ocriplasmin success based on proper patient selection
Published: July 1st 2015 | Updated:
Advertisement
Advertisement
.png "Optometry Times"){kind=logo}
